T. Lam

Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.

M. Alavi, G. Dore, L. Degenhardt, 2021, The International journal on drug policy.

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.

M. Alavi, P. Read, A. Milat, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Update on global epidemiology of viral hepatitis and preventive strategies

H. Rashid, Bisma Rauff, T. Lam, 2018, World journal of clinical cases.

Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatment.

M. Alavi, V. Wiseman, G. Dore, 2022, Drug and alcohol dependence.

COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out

M. Douglas, H. Rashid, M. Eslam, 2022, Vaccines.

A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study

M. Alavi, P. Read, A. Milat, 2022, Viruses.

Helicobacter pylori eradication therapy: indications, efficacy and safety

R. Leong, P. Katelaris, T. Lam, 2008 .